Parallel Advisors, LLC Organogenesis Holdings Inc. Transaction History
Parallel Advisors, LLC
- $4.34 Billion
- Q4 2024
A detailed history of Parallel Advisors, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 88 shares of ORGO stock, worth $413. This represents 0.0% of its overall portfolio holdings.
Number of Shares
88Holding current value
$413% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding ORGO
# of Institutions
123Shares Held
61.8MCall Options Held
4.3KPut Options Held
3.9K-
Soleus Capital Management, L.P. Greenwich, CT12.5MShares$58.7 Million2.78% of portfolio
-
Morgan Stanley New York, NY11.8MShares$55.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$16.9 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA3.08MShares$14.5 Million0.03% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $615M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...